NASDAQ
Hansa Biopharma AB (HNSBF) has a fcf yield of -25.21% as of Monday, August 3, 2026. This represents a 16.59% increase compared to its 12-month average of -30.22%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.